Sign in
PAVMZ Stock Price, Chart, Stats & News
PAVmed Inc
Save
PAVmed Inc (PAVMZ) does not currently pay a dividend.
11,923
Market cap
–
Current P/E
–
Forward P/E
PAVMZ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -668.97% |
Operating margin | -69627.59% |
Pretax margin | 4931.03% |
Net margin | 10672.41% |
Effective tax rate | – |
ROA | 8.13% |
ROE | 10.23% |
D/E | 0.26x |
Interest coverage ratio | -877.91x |
PAVMZ valuation
P/E | – |
P/S | 160.56x |
P/B | 0.17x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.02x |
EV multiple | -0.95x |
About
PAVmed Inc. functions as a medical technology enterprise based in the United States. Its primary offerings feature CarpX, a patented, single-use, disposable, and minimally invasive surgical tool developed for addressing carpal tunnel syndrome. The company also provides EsoCheck, an esophageal cell collection device facilitating the early identification of esophageal adenocarcinoma and Barrett's Esophagus (BE), along with EsoGuard, an advanced DNA assay utilizing bisulfite-converted next-generation sequencing.
Similar securities
Based on sector and market capitalization
Report issue